Applicant profile
ASAHI INTECC CO., LTD.
Asahi Intecc
Hong Kong MDACS·Japan·18 registered devices·Jun 16, 2016 – Apr 18, 2024
18
Total devices
2
Risk classes
2016
First registration
2024
Most recent
Applicant overview
Bilingual manufacturer details sourced from Hong Kong MDACS
- Applicant (EN)
- ASAHI INTECC CO., LTD.
- Applicant (ZH)
- Asahi Intecc
- Country
- Japan日本
- Address
- 3-100 Akatsuki-cho, Seto, Aichi, 489-0071, Japan赤月町3-100, 濑户, 爱知县, 489-0071, 日本
Timeline
- First registration
- Jun 16, 2016
- Most recent
- Apr 18, 2024
Risk class breakdown
II
2
IV
16
Recent MDACS registrations
Latest 15 devices linked to this applicant
| Device | Risk class | Authorised rep | Registered |
|---|---|---|---|
| Catheters, Vascular, Guiding 导管,血管,引导 | IV | ConMed Limited 康明医疗有限公司 | Apr 18, 2024 |
| Catheters, Vascular, Infusion, Coronary Artery 导管、血管、输液、冠状动脉 | IV | ConMed Limited 康明医疗有限公司 | Jan 09, 2024 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Dec 08, 2023 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Oct 26, 2023 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Nov 04, 2022 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Sep 01, 2022 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Sep 01, 2022 |
| Catheters, Vascular, Guiding 导管,血管,引导 | IV | ConMed Limited 康明医疗有限公司 | May 31, 2022 |
| Catheters, Vascular, Guiding 导管,血管,引导 | II | ConMed Limited 康明医疗有限公司 | Jan 04, 2022 |
| Catheters, Vascular, Guiding 导管,血管,引导 | IV | ConMed Limited 康明医疗有限公司 | Jan 04, 2022 |
| Catheters, Vascular, Guiding 导管,血管,引导 | IV | ConMed Limited 康明医疗有限公司 | Jun 24, 2021 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Apr 09, 2021 |
| Catheters, Vascular, Guiding 导管,血管,引导 | IV | ConMed Limited 康明医疗有限公司 | Feb 03, 2021 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Feb 03, 2021 |
| Guide Wires 导丝 | IV | ConMed Limited 康明医疗有限公司 | Dec 03, 2020 |
About this profile
ASAHI INTECC CO., LTD. is associated with 18 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.